Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-20
DOI
10.1038/srep41144
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glycosyltransferases and non-alcoholic fatty liver disease
- (2016) Yu-Tao Zhan WORLD JOURNAL OF GASTROENTEROLOGY
- Therapeutic efficacy of ethanolic extract of Aerva javanica aerial parts in the amelioration of CCl4-induced hepatotoxicity and oxidative damage in rats
- (2016) Ahmed H. Arbab et al. Food & Nutrition Research
- Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials
- (2016) Shira Zelber-Sagi et al. Therapeutic Advances in Gastroenterology
- Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
- (2016) Davide Povero et al. Diabetes & Metabolism Journal
- A review of biotransformation and pharmacology of ginsenoside compound K
- (2015) Xi-Ding Yang et al. FITOTERAPIA
- Protective Effect of Panax notoginseng Saponins on Acute Ethanol-Induced Liver Injury Is Associated with Ameliorating Hepatic Lipid Accumulation and Reducing Ethanol-Mediated Oxidative Stress
- (2015) Ren-Bo Ding et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5′monophosphate kinase: A study in vitro and in vivo
- (2015) Shengnan Wei et al. LIFE SCIENCES
- Saponins ofPanax notoginseng: chemistry, cellular targets and therapeutic opportunities in cardiovascular diseases
- (2014) Jingjing Liu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Gadoxetic Acid-Enhanced MRI and Sonoelastography: Non-Invasive Assessments of Chemoprevention of Liver Fibrosis in Thioacetamide-Induced Rats with Sho-Saiko-To
- (2014) Ya-Wen Chen et al. PLoS One
- Ameliorative Potential ofTamarindus indicaon High Fat Diet Induced Nonalcoholic Fatty Liver Disease in Rats
- (2014) Suja Rani Sasidharan et al. TheScientificWorldJOURNAL
- Osthol attenuates hepatic steatosisviadecreased triglyceride synthesis not by insulin resistance
- (2014) Ho Hyun Nam WORLD JOURNAL OF GASTROENTEROLOGY
- Prevalence of nonalcoholic fatty liver disease in mainland of China: A meta-analysis of published studies
- (2013) ZhanZhan Li et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacological agents for NASH
- (2013) Vlad Ratziu Nature Reviews Gastroenterology & Hepatology
- Panax notoginseng and its components decreased hypertension via stimulation of endothelial-dependent vessel dilatation
- (2012) Chunshui Pan et al. VASCULAR PHARMACOLOGY
- Animal models for the study of liver fibrosis: new insights from knockout mouse models
- (2011) Hiromitsu Hayashi et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Ginsenoside Rb1 Inhibits Cell Activation and Liver Fibrosis in Rat Hepatic Stellate Cells
- (2011) Yu-Ting Lo et al. JOURNAL OF MEDICINAL FOOD
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings
- (2010) Elizabeth M. Brunt et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started